The site will be unavailable in 36 minutes for scheduled maintenance.

$1.62 -0.99 (-37.93%)
2/10/2012 4:05 PM

K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Featured Broker Partners


Advertisement